Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells

Inflammation

Volumn 34, Issue 3, 2011, Pages 209-221

  Lee, Chun Chung ^a   Liu, Ko Jiunn ^a   Wu, Yu Chen ^a   Lin, Sue Jane ^b   Chang, Ching Chun ^c   Huang, Tze Sing ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Akt; MMP 9; sesamin; tumor angiogenesis; tumor associated macrophage; VEGF

Indexed keywords

GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SESAMIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; CANCER CELL; CELL NUCLEUS; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VASCULARIZATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; DIOXOLES; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERLEUKIN-6; INTERLEUKIN-8; LIGNANS; MACROPHAGES; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; RNA, NEOPLASM; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

SESAMUM INDICUM;

EID: 79956139299     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9226-z     Document Type: Article

References (37)

1. Balkwill, F. 2004. Cancer and the chemokine network. Nature Reviews. Cancer 4: 540-550. (Pubitemid 38868623)
2. van Kempen, L.C., K.E. de Visser, and L.M. Coussens. 2006. Inflammation, proteases and cancer. European Journal of Cancer 42: 728-734.
3. Bingle, L., N.J. Brown, and C.E. Lewis. 2002. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. The Journal of Pathology 196: 254-265. (Pubitemid 34189413)
4. Lee, C.C., K.J. Liu, and T.S. Huang. 2006. Tumor-associated macrophage: Its role in tumor angiogenesis. Journal of Cancer Molecules 2: 135-140.
5. Lewis, C., and C. Murdoch. 2005. Macrophage responses to hypoxia: Implications for tumor progression and anti-cancer therapies. The American Journal of Pathology 167: 627-635. (Pubitemid 41216349)
6. Vicioso, L., F.J. Gonzalez, M. Alvarez, N. Ribelles, M. Molina, A. Marquez, L. Perez, A. Matilla, and E. Alba. 2006. Elevated serum levels of vascular endothelial growth factor are associated with tumor-associated macrophages in primary breast cancer. American Journal of Clinical Pathology 125: 111-118. (Pubitemid 43089733)
7. Leek, R.D., and A.L. Harris. 2002. Tumor-associated macrophages in breast cancer. Journal of Mammary Gland Biology and Neoplasia 7: 177-189. (Pubitemid 38420774)
8. Lee, A.H., L.C. Happerfield, L.G. Bobrow, and R.R. Millis. 1997. Angiogenesis and inflammation in invasive carcinoma of the breast. Journal of Clinical Pathology 50: 669-673. (Pubitemid 27396070)
9. Goede, V., L. Brogelli, M. Ziche, and H.G. Augustin. 1999. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. International Journal of Cancer 82: 765-770. (Pubitemid 29356979)
10. Sunderkotter, C., M. Goebeler, K. Schulze-Osthoff, R. Bhardwaj, and C. Sorg. 1991. Macrophage-derived angiogenesis factors. Pharmacology & Therapeutics 51: 195-216.
11. Condeelis, J., and J.W. Pollard. 2006. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 124: 263-266. (Pubitemid 43121975)
12. Lewis, C.E., and J.W. Pollard. 2006. Distinct role of macrophages in different tumor microenvironments. Cancer Research 66: 605-612. (Pubitemid 43165918)
13. Pollard, J.W. 2004. Tumour-educated macrophages promote tumour progression and metastasis. Nature Reviews. Cancer 4: 71-78. (Pubitemid 38082155)
14. Lee, C.C., K.J. Liu, L.L. Chen, Y.C. Wu, and T.S. Huang. 2006. Tumor necrosis factor-α, interleukin-8 and interleukin-6 are involved in vascular endothelial cell capillary tube and network formation induced by tumor-associated macrophages. Journal of Cancer Molecules 2: 155-160.
15. Lee, C.C., P.R. Chen, S. Lin, S.C. Tsai, B.W. Wang, W.W. Chen, et al. 2004. Sesamin induces nitric oxide and decreases endothelin-1 production in HUVECs: Possible implications for its antihypertensive effect. Journal of Hypertension 22: 2329-2338. (Pubitemid 39620283)
16. Nakano, D., D. Kurumazuka, Y. Nagai, A. Nishiyama, Y. Kiso, and Y. Matsumura. 2008. Dietary sesamin suppresses aortic NADPH oxidase in DOCA salt hypertensive rats. Clinical and Experimental Pharmacology & Physiology 35: 324-326.
17. Miyake, Y., S. Fukumoto, M. Okada, K. Sakaida, Y. Nakamura, and T. Osawa. 2005. Antioxidative catechol lignans converted from sesamin and sesaminol triglucoside by culturing with Aspergillus. Journal of Agricultural and Food Chemistry 53: 22-27. (Pubitemid 40066464)
18. Nakano, D., C.J. Kwak, K. Fujii, K. Ikemura, A. Satake, M. Ohkita, et al. 2006. Sesamin metabolites induce an endothelial nitric oxide-dependent vasorelaxation through their antioxidative property-independent mechanisms: Possible involvement of the metabolites in the antihypertensive effect of sesamin. The Journal of Pharmacology and Experimental Therapeutics 318: 328-335.
19. Yokota, T., Y. Matsuzaki, M. Koyama, T. Hitomi, M. Kawanaka, M. Enoki-Konishi, et al. 2007. Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells. Cancer Science 98: 1447-1453. (Pubitemid 47241769)
20. Tsai, S.C., Y.C. Liu, C.P. Li, T.S. Huang, and C.C. Lee. 2006. Sesamin inhibits vascular endothelial cell growth and angiogenic activity of lung adenocarcinoma cells. Journal of Cancer Molecules 2: 199-205.
21. Cutolo, M., G. Carruba, B. Villaggio, D.A. Coviello, J.M. Dayer, I. Campisi, et al. 2001. Phorbol diester 12-O-tetradecanoylphorbol 13-acetate (TPA) up-regulates the expression of estrogen receptors in human THP-1 leukemia cells. Journal of Cellular Biochemistry 83: 390-400. (Pubitemid 33027484)
22. Hawinkels, L.J., K. Zuidwijk, H.W. Verspaget, E.S. de Jonge-Muller, W. van Duijn, V. Ferreira, et al. 2008. VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. European Journal of Cancer 44: 1904-1913.
23. Sica, A., T. Schioppa, A. Mantovani, and P. Allavena. 2006. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy. European Journal of Cancer 42: 717-727.
24. Sica, A., P. Allavena, and A. Mantovani. 2008. Cancer related inflammation: The macrophage connection. Cancer Letters 267: 204-215.
25. Sica, A., L. Rubino, A. Mancino, P. Larghi, C. Porta, M. Rimoldi, et al. 2007. Targeting tumour-associated macrophages. Expert Opinion on Therapeutic Targets 11: 1219-1229. (Pubitemid 47527326)
26. Toi, M., S. Hoshina, T. Takayanagi, and T. Tominaga. 1994. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Japanese Journal of Cancer Research 85: 1045-1049. (Pubitemid 24325027)
27. Leek, R.D., R.J. Landers, A.L. Harris, and C.E. Lewis. 1999. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. British Journal of Cancer 79: 991-995. (Pubitemid 29082138)
28. Tsutsui, S., K. Yasuda, K. Suzuki, K. Tahara, H. Higashi, and S. Era. 2005. Macrophage infiltration and its prognostic implications in breast cancer: The relationship with VEGF expression and microvessel density. Oncology Reports 14: 425-431.
29. Murdoch, C., A. Giannoudis, and C.E. Lewis. 2004. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104: 2224-2234. (Pubitemid 39331817)
30. Giraudo, E., M. Inoue, and D. Hanahan. 2004. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. The Journal of Clinical Investigation 114: 623-633. (Pubitemid 39578752)
31. Wegiel, B., A. Bjartell, Z. Culig, and J.L. Persson. 2008. Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. International Journal of Cancer 122: 1521-1529. (Pubitemid 351294960)
32. Knall, C., G.S. Worthen, and G.L. Johnson. 1997. Interleukin 8- stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proceedings of the National Academy of Sciences of the United States of America 94: 3052-3057.
33. Hanna, A.N., E.Y. Chan, J. Xu, J.C. Stone, and D.N. Brindley. 1999. A novel pathway for tumor necrosis factor-alpha and ceramide signaling involving sequential activation of tyrosine kinase, p21(ras), and phosphatidylinositol 3-kinase. The Journal of Biological Chemistry 274: 12722-12729. (Pubitemid 29215512)
34. Kazi, A.A., K.H. Molitoris, and R.D. Koos. 2009. Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus. Biology of Reproduction 81: 378-387.
35. Ozes, O.N., L.D. Mayo, J.A. Gustin, S.R. Pfeffer, L.M. Pfeffer, and D.B. Donner. 1999. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85.
36. Srivastava, A.K., X. Qin, N. Wedhas, M. Arnush, T.A. Linkhart, R.B. Chad-wick, et al. 2007. Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway. The Journal of Biological Chemistry 282: 35113-35124. (Pubitemid 350232481)
37. Martin, P., and S.J. Leibovich. 2005. Inflammatory cells during wound repair: The good, the bad and the ugly. Trends in Cell Biology 15: 599-607. (Pubitemid 41619424)